World News Insights
1-3 Minute Gist
Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
All Topics Group
FDA and the drug safety, production and marketing practices of pharmaceutical companies.
07/01/2005
The increasing controversy surrounding the safety and marketing of many pharmaceutical products and the role of the FDA in ensuring safe use and avoiding risks to users.
Grouped Articles
New F.D.A.: Transparence and Flexibility
New York Times 09.24.2010
FDA Plan Would Aid Drug Makers in Liability Suits
Wall Street Journal 01.14.2006
FDA Moves Toward Harder Line on Suicide Risks
Wall Street Journal 07.01.2005
Baxter Infusion Pumps Are Target of FDA Probe
Wall Street Journal 07.22.2005
Financial Ties to Industry Cloud Major Depression Study
Wall Street Journal 07.11.2006
Avandia Concerns Reopen a Wider Debate
Wall Street Journal 05.23.2007
China Sentences Former Drug Regulator to Death
New York Times 05.29.2007
Wall Street Journal 05.29.2007
Congress Zeroes In on Roles Of FDA, Glaxo on Avandia
Wall Street Journal 06.07.2007
BusinessWeek 07.02.2007
Wall Street Journal 07.31.2007
FDA Says Aventis Failed To Act on Ketek Drug Fears
Wall Street Journal 10.25.2007
Bayer Drug May Raise Risk of Death, FDA Says
Wall Street Journal 10.26.2007
Insulin Flop Costs Pfizer $2.8 Billion
Wall Street Journal 10.19.2007
Wall Street Journal 12.01.2007
Big Pharma Faces Grim Prognosis
Wall Street Journal 12.06.2007
Drug Companies Face Political, Scientific Attacks
Wall Street Journal 01.23.2008
China Plant Played Role In Drug Tied to 4 Deaths
Wall Street Journal 02.14.2008
Wall Street Journal 02.27.2008
How Heparin Maker in China Tackles Risks
Wall Street Journal 03.10.2008
FDA to Hire Additional Scientists To Expand Drug Safety Operations
Wall Street Journal 04.30.2008
BusinessWeek 06.26.2008
Drug Industry to Announce Revised Code on Marketing
New York Times 07.10.2008
Amgen Told to Reword Drug Label
New York Times 07.31.2008
Making a Name for Drugs Without Using Their Names
Wall Street Journal 08.29.2008
Merck Ends Development of Obesity Drug
Wall Street Journal 10.03.2008
U.S. Drug Ban Hits Ranbaxy, Indian Maker of Generics
Wall Street Journal 09.17.2008
Drug Makers, Facing Critics, Will Stop Some Ads
Wall Street Journal 12.11.2008
F.D.A. Eases Off-Label Drug Rules
New York Times 01.13.2009
FDA Finalizes Medical Journal Promotion Rules
Wall Street Journal 01.14.2009
BusinessWeek 01.15.2009
F.D.A. Finds ‘Natural’ Diet Pills Laced With Drugs
New York Times 02.10.2009
Political Lobbying Drove FDA Process
Wall Street Journal 03.06.2009
Anticlotting Drug Faces Panel Vote
Wall Street Journal 03.18.2009
Federal Workers, Regulations to Increase
Wall Street Journal 05.08.2009
FDA Weighs the Risks of Rituxan
Wall Street Journal 06.01.2009
Drug Agency May Reveal More Data on Actions
New York Times 06.02.2009
New F.D.A. Chief Says She’ll Toughen Enforcement Efforts
New York Times 06.17.2009
Drug Firms' Medical Staffs Say What Salespeople Can't
Wall Street Journal 06.26.2009
F.D.A. Reveals It Fell to a Push by Lawmakers
New York Times 09.25.2009
Drug Makers to Press for Guidance on Web Marketing
Wall Street Journal 11.12.2009
Doctors' Spat Exposes FDA Loophole
Wall Street Journal 12.23.2009
AstraZeneca Sharpens Focus on Drug Ethics
Wall Street Journal 12.23.2009
Questions for Makers on Defects in Drugs
New York Times 05.26.2010
Maker Plays Up Sexual Disorder, With a Pill in Waiting
New York Times 06.16.2010
Regulator Defends Avastin Decision
Wall Street Journal 01.07.2011
FDA Says Drug Firms Didn't Finish Follow-Ups
Wall Street Journal 02.09.2011
Pressure to Link Drugs and âCompanion Diagnosticsâ
New York Times 12.26.2011
FDA Panelists Had Ties to Bayer
Wall Street Journal 01.11.2012
How Glaxo Marketed a Malady to Sell a Drug - WSJ.com
Wall Street Journal 10.25.2006
Abbott Laboratories to pay $1.6 billion over illegal marketing of Depakote - The Washington Post
Washington Post 05.08.2012
Cephalon Used Improper Tactics To Sell Drug, Probe Finds - WSJ.com
Wall Street Journal 11.21.2006
Marketing New Antismoking Pill Poses Challenges for Pfizer - WSJ.com
Wall Street Journal 11.22.2006
Pfizer to Cut 20% Of U.S. Sales Force, Signaling End of Era - WSJ.com
Wall Street Journal 11.29.2006
Anemia drug made billions, but at what cost? - The Washington Post
Washington Post 07.20.2012
FDA Cancer Czar Stirs Debate On Agency's Role
Wall Street Journal 03.12.2008
Stronger Warnings on 3 Drugs for Anemia
New York Times 11.09.2007
Amgen's Star Fades Amid Safety Questions
Wall Street Journal 04.10.2007
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1
Terms and Conditions | Copyright Policy | Privacy Policy | Contact Us